Mrs Aurelia G Mendiola Long, NURSE PRACTITIONER | |
5 Canal Street, San Jose, Tinian, MP 96952 | |
(670) 433-4750 | |
(670) 433-4751 |
Full Name | Mrs Aurelia G Mendiola Long |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Women's Health |
Location | 5 Canal Street, San Jose, Tinian, Northern Mariana Islands |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1619182565 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Mrs Aurelia G Mendiola Long, NURSE PRACTITIONER P.o. Box 5723 Chrb, Saipan, MP 96950 Ph: (670) 783-2468 | Mrs Aurelia G Mendiola Long, NURSE PRACTITIONER 5 Canal Street, San Jose, Tinian, MP 96952 Ph: (670) 433-4750 |
News Archive
ImmunoCellular Therapeutics, Ltd. today announced the establishment of an agreement with PharmaCell B.V. to provide contract manufacturing services for the European production of ICT-107, a dendritic cell-based cancer immunotherapy in development as a potential treatment for glioblastoma (GBM).
A UCLA-led group of researchers tracing disparities in life expectancy between blacks and whites in the U.S. has found that white males live about seven years longer on average than African American men and that white women live more than five years longer than their black counterparts.
Routine criminal prosecutions for not disclosing HIV status should be abolished, write three HIV/AIDS experts in an article in CMAJ.
40 percent of people in the EU suffer from non-alcoholic steatohepatitis (fatty liver disease), a disease which is becoming increasingly more frequent as a result of diabetes and excess weight in an affluent society. Currently, it is not possible to forecast the further course of the disease - right up to cirrhosis and cancer of the liver. Furthermore, an increased risk of heart attack and kidney damage exists. In future, this should become possible using a Risk Score with different biomarkers.
Oncology researchers studying high-risk children's cancers have identified a protein that offers a likely target for immunotherapy-harnessing the immune system in medical treatments. In cell cultures and animal models, a potent drug attached to an antibody selectively zeroes in on cancer cells without harming healthy cells.
› Verified 9 days ago